Search

Author/Creator Stegeman, C.

1. Clinical Outcomes of Remission Induction Therapy for Severe Antineutrophil Cytoplasmic Antibody–Associated Vasculitis. Issue 9 (26th August 2013)

Authors:
Miloslavsky, E. M.; Specks, U.; Merkel, P. A.; Seo, P.; Spiera, R.; Langford, C. A.; Hoffman, G. S.; Kallenberg, C. G. M.; St.Clair, E. W.; Tchao, N. K.; Viviano, L.; Ding, L.; Sejismundo, L. P.; Mieras, K.; Iklé, D.; Jepson, B.; Mueller, M.; Brunetta, P.; Allen, N. B.; Fervenza, F. C.
Journal:
Arthritis and rheumatism
Issue:
Volume 65:Issue 9(2013:Sep.)
Page Start:
2441
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Clinical Outcomes of Remission Induction Therapy for Severe Antineutrophil Cytoplasmic Antibody–Associated Vasculitis1. Issue 9 (26th August 2013)

Authors:
Miloslavsky, E. M.; Specks, U.; Merkel, P. A.; Seo, P.; Spiera, R.; Langford, C. A.; Hoffman, G. S.; Kallenberg, C. G. M.; St.Clair, E. W.; Tchao, N. K.; Viviano, L.; Ding, L.; Sejismundo, L. P.; Mieras, K.; Iklé, D.; Jepson, B.; Mueller, M.; Brunetta, P.; Allen, N. B.; Fervenza, F. C.
Journal:
Arthritis and rheumatism
Issue:
Volume 65:Issue 9(2013:Sep.)
Page Start:
2441
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. FRI0510 Increased expression of v-domain ig suppressor of t-cell activation (VISTA) on leukocytes of granulomatosis with polyangiitis (GPA) patients. (12th June 2018)

Authors:
Hid Cadena, R.; Yuan, J.; Huitema, M.G.; Boots, A.M.; Stegeman, C.; Brouwer, E.; Rutgers, A.; Heeringa, P.; Abdulahad, W.H.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 77(2018)Supplement 2
Page Start:
782
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. OP0316 Increased expression of microrna-142–3p is associated with the functional defect of regulatory t cells in anti-neutrophil cytoplasmic antibody associated vasculitis. (12th June 2018)

Authors:
Dekkema, G.; Bijma, T.; Abdulahad, W.; Jellema, P.; Van Den Berg, A.; Kroesen, B.J.; Stegeman, C.; Heeringa, P.; Sanders, J.-S.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 77(2018)Supplement 2
Page Start:
204
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Rituximab for the Treatment of Relapses in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis1. Issue 11 (November 2014)

Authors:
Miloslavsky, E. M.; Specks, U.; Merkel, P. A.; Seo, P.; Spiera, R.; Langford, C. A.; Hoffman, G. S.; Kallenberg, C. G. M.; St.Clair, E. W.; Tchao, N. K.; Viviano, L.; Ding, L.; Iklé, D.; Villarreal, M.; Jepson, B.; Brunetta, P.; Allen, N. B.; Fervenza, F. C.; Geetha, D.; Keogh, K.
Journal:
Arthritis & rheumatology
Issue:
Volume 66:Issue 11(2014)
Page Start:
3151
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗